July 20, 2021
July 20, 2021 –
The U.S. FDA has requested that statin manufacturers remove a contraindication from
their products’ prescribing information
July 20, 2021
July 20, 2021 –
Albireo Pharma’s BylvayTM (odevixibat) has become the first drug approved by the U.S. FDA
to treat pruritus in individuals who are at least three months
July 20, 2021
July 20, 2021 –
The U.S. FDA has approved a new indication for Octagam® 10% [immune globulin intravenous (human)] to treat adult dermatomyositis, a rare inflammatory
July 16, 2021
July 16, 2021 –
The U.S. FDA has approved an expanded indication for Prograf® (tacrolimus – Astellas Pharma)
July 16, 2021
July 16, 2021 –
The U.S. FDA has approved RezurockTM (belumosudil), manufactured by Kadmon Holdings,
to treat chronic graft-versus-host
July 16, 2021
July 16, 2021 –
The U.S. FDA has approved VaxneuvanceTM (pneumococcal 15-valent conjugate vaccine –
Merck) for active immunization to prevent invasive disease
July 16, 2021
July 16, 2021 –
The U.S. FDA has approved Sanofi’s fexinidazole tablets to treat both stages of sleeping
sickness (human African trypanosomiasis, or HAT) caused by Trypanosoma
July 12, 2021
July 12, 2021 –
The U.S. FDA is requiring an expanded black box warning for hydroxyethyl